Patent · US Active

Certain protein kinase inhibitors

US9567342B2 · kind B2 · utility

0Cited by

1References

20Claims

0Family size

Assignees

Shanghai Fochon Pharmaceutical Co., Ltd. · CN
SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES · CN

Inventors

Weibo Wang · Moraga, US
Meiyu Geng · Shanghai, CN
Jian Ding · Shanghai, CN
Xingdong Zhao · Chongqing, CN
Jing Ai · Shanghai, CN
Qiang Tian · Sichuan, CN
Xia Peng · Shanghai, CN
Weipeng ZHANG · Chongqing, CN
Hongbin Liu · Beijing, CN
Haohan TAN · Chongqing, CN
Ling Chen · Shanghai, CN

Key dates

Filing date	Oct 29, 2015
Grant date	Feb 14, 2017
Priority date	—
Expiry date	Oct 29, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D405/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed herein are protein kinase inhibitors, more particularly novel pyrimidine derivatives and pharmaceutical compositions thereof, and method of use thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.